Enviva Inc.
EVA · NYSE
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $2 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.5% | 6.2% | 12.2% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -86.1% | 16.3% | 13.8% | -7% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -101.9% | -1.5% | 1% | -6.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -136.9% | -26.6% | -18.5% | -43.4% |
| EPS Diluted | -6.1 | -1.14 | -0.81 | -1.73 |
| % Growth | -435.1% | -40.7% | 53.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |